Clinical trial
Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a…
NCT00403364 · IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other · Completed
Key facts
| NCT number | NCT00403364 |
|---|---|
| Title | Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial |
| Official title | Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Helicobacter Pylori Infection |
| Intervention type | Drug |
| Interventions | Placebo amoxicillin pantoprazole clarithromycin tinidazole |
| Enrollment | 300 |
| Start date | Jul 1, 2003 |
| Completion | Feb 1, 2006 |
| First posted | Nov 23, 2006 |
| Last update posted | Mar 18, 2021 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: